Pharmaceutical company payments to Japanese breast cancer practice guideline authors

Abstract Background The creation of breast cancer practice guidelines requires proper management of financial relationships with drug companies, as they can introduce conflicts of interest (COIs) among guideline authors. However, little is known about the specific landscape and fraction of financial...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Anju Murayama, Kenichi Higuchi, Keerthana R. Byreddy, Kugo Hinari, Yuki Senoo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2024-06-01
Serie:	Clinical and Translational Discovery
Soggetti:	clinical practice guideline conflicts of interest ethics evidence‐based medicine health policy pharmaceutical companies
Accesso online:	https://doi.org/10.1002/ctd2.304
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!